期刊文献+

基于11C-MET PET-CT与MRI对脑胶质瘤精确放疗GTV勾画的比较研究 被引量:4

Comparative evaluation of 11C-MET PET-CT and MRI for GTV delineation in precision radiotherapy for gliomas
原文传递
导出
摘要 目的 探讨11C-MET PET-CT和MRI图像对脑胶质瘤GTV确定的差异.方法 选取6例经病理证实为胶质瘤患者的术前MRI及11C-MET PET-CT图像,分别由我科5位医师在两种图像资料上勾画GTV,比较两者差异.结果 在MRI11C-MET PET-CT上勾画的GTV体积相似(P=0.917),GTV变异系数也相似(P =0.600).勾画的GTV重合度最大为73.0%、最小为51.8%.方差分析显示不同勾画者之间在两种图像资料上勾画的GTV相似(P =0.709),但PET-CT组GTV最大差值为27.66 cm3,而MRI组的为40.37 cm3.结论 MRI与PET-CT显示的肿瘤边界存在差异,不同勾画者勾画的GTV相似,PET-CT组的GTV最大差值较MRI组的小,11C-MET PET-CT显示GTV较为直观. Objective To evaluate the difference between MRI and n C-MET PET-CT for gross tumor volume (GTV) delineation in the precision radiotherapy for gliomas. Methods Six patients with a pathologically confirmed diagnosis of gliomas were selected for target delineation. Five physicians in our department were called to delineate the GTV based on the preoperative MRI and n C-MET PET-CT images of these patients. The GTVs based on the two methods were compared. Results There was no significant difference between the GTVs based on MRI and n C-MET PET-CT (P = 0. 917), and their coefficients of variation were also similar ( P = 0. 600). The coincidences of GTVs were different among the patients, with a maximum value of 73.0% and a minimum value of 51.8%. GTV showed no significant difference when defined by different physicians on MRI and PET-CT (P = 0. 709) ; the biggest difference was 27. 66 cm3 on PET-CT and 40. 37 cm3 on MRI. Conclusions The boundaries of gliomas defined on MRI and PET-CT are different. The GTVs delineated by different physicians on MRI and PET-CT are similar, and the biggest difference on PET-CT is smaller than that on MRI, which suggests that 11C-MET PET-CT is a more direct way for displaying GTV.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2014年第2期143-146,共4页 Chinese Journal of Radiation Oncology
基金 安徽省科技攻关计划项目(07010302202)
关键词 脑肿瘤 体层摄影术 正电子发射型 11C-蛋氨酸 磁共振成像 大体肿瘤体积勾画 Brain neoplasms Tomography, positron-emission, n C-methionine Magnetic resonance imaging Gross tumor volume delineation
  • 相关文献

参考文献15

  • 1Niyazi M,Geisler J,Siefert A,et al.FET-PET-CT for malignant glioma treatment planning[J].Radiother Oncol,2011,99:44-48.
  • 2Scoccianti S,Magrini SM,Ricardi U,et al.Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007:a multicenter study by the Central Nervous System Study Group of IARO (Italian Association of Radiation Oncology)[J].Neurosurgery,2010,67:446-458.
  • 3Chiti A,Kirienko M,Gregoire V.Clinical use of PET-CT/CT data for radiotherapy planning:what are we looking for[J]? Radiother Oncol,2010,96:277-279.
  • 4杨荣水,吴华,潘卫民.功能成像在肿瘤生物适形调强放疗中的应用进展[J].国际医学放射学杂志,2010,33(3):235-239. 被引量:3
  • 5Pauleit D,Floeth F,Hamacher K,et al.O-(2-18F-fluoroethy)-L-tyrosine PET-CT combined with MRI improves the diagnostic assessment of cerebral gliomas[J].Brain,2005,128:678-687.
  • 6Ortega-López N,Mendoza-V(a)squez RG,Adame-Ocampo G,et al.Validation of MRI and 18F-FDG PET-CT coregistration in patients with primary brain tumors[J].Gac Med Mex,2007,143:309-316.
  • 7Gregoire V,Chiti A.PET-CT in radiotherapy planning:particularly exquisite test or pending and experimental tool[J]? Radiother Oncol,2010,96:275-276.
  • 8Chen W.Clinical applications of PET-CT in brain tumors.J Nucl Med,2007,48:1468-1481.
  • 9Goldman S.PET-CT for diagnosis and therapy of brain tumors[J].Med Nucl,2011,35:347-351.
  • 10Anca-Ligia G,Sabrina TA,Eva R,et al.An interindividual comparison of O-(2-[1sF]fluoroethy-L-tyrosine (FET)-and L-[methyl-11 C]methionine (MET)-PET-CT in Patients with brain gliomas and metastases[J].Int J Radiat Oncol Biol Phys,2011,63:142-145.

二级参考文献36

  • 1Burri RJ, Rangaswamy B, Kostakoglu L, et al. Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck [J ]. Int J Radiat Oncol Biol Phys,2008,71: 682-628.
  • 2Lin Z, Mechalakos J, Nehmeh S, et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on ^18F- FMISO positron emission tomography [J ]. Int J Radiat Oncol Biol Phys,2008,70: 1219-1228.
  • 3Fuss M,Wenz F,Essig M,et al.Tumor angiogengsis of low-grade astrocytomas measure by dynamic susceptibility contrast-enhanced MRI (DSCMRI) is predicitve of local tumor control after radiation therapy [ J ].Int J Radiat Oncol Biol Phys,2001,51:478.
  • 4Haubner R,Wester HJ,Weber WA,et al.Non-invasive imaging of ab3 integrin expression using a ^18F-labeled RGD-containing glycopeptides and positron emission tomography [J ]. Cancer Res, 2001,61 : 1781.
  • 5Kurhanewicz J, Vigneron DB, Nelson SJ. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer[J]. Nenplasia,2000,2(1-2):166-189.
  • 6Hams MA,Schwartsmann G,Bemard RA,et al.Phenotype modulation of cellular UV-Senditivity [ J ] .Cancer Lett, 1999,145( 1-2):65 -72.
  • 7Blankenberg FG, Tait JF, Strauss HW, et al. Apoptotic cell death: its implication for imaging in the next millennium[J]. Eur J Nucl Med, 2000,27:359-367.
  • 8Sartor Cl.Biological modifiers as potential radiosensitizers:targeting the epidermal growth factor receptor family [J ]. Semin Oncol,2000, 27(6 Suppl 11):15-20.
  • 9Pillai MR,Jayaprakash PG,Nair MK.Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix [J ]. J Cancer Res Clin Oncol, 1998,124:456-461.
  • 10Ling CC, Burman C,Chui CS,et al.Perspective of muhidimengsional conformal radiation treatment [ J ]. Radiother Oncol, 1993,29:129- 139.

共引文献2

同被引文献33

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部